Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiupel, M.
Right arrow Articles by Bostock, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiupel, M.
Right arrow Articles by Bostock, D.

Veterinary Pathology, Vol 36, Issue 4 292-300, Copyright © 1999 by American College of Veterinary Pathologists


ARTICLES

Prognostic factors for treated canine malignant lymphoma

M. Kiupel, E. Teske and D. Bostock
Institut fur Veterinar-Pathologie der Freien Universitat Berlin, Germany.

The aim of this study was to investigate the prognostic importance of different clinical, immunohistologic and tumor proliferation characteristics in dogs with malignant lymphoma treated with chemotherapy. From 74 dogs with malignant lymphoma at least one enlarged peripheral lymph node was taken for biopsy before chemotherapy following a standardized protocol (vincristine, cyclophosphamide, prednisolone, doxorubicin, and L-asparaginase). The variables evaluated as prognostic factors were age, sex, and tumor stage, as well as histomorphologic grade (Kiel classification, Working Formulation), immunophenotype (using markers for CD3 and CD79a), and cell proliferation (Ki-67, proliferation cell nuclear antigen, mitotic index, and argyrophil nucleolar organizer regions [AgNORs]) in extirpated lymph nodes. All markers were used on routinely formalin-fixed, paraffin-embedded tissues. The AgNORs were assessed qualitatively, based on the AgNOR pattern distribution, and quantitatively using image analysis and routine counting. In both univariate and multivariate survival analyses, AgNORs were a valuable prognostic marker for the treatment of canine malignant lymphomas. Based on the results of the multivariate analysis longer survival time correlated with a B-cell type, a larger mean AgNOR area, a larger total AgNOR area, a shorter distance between two AgNORs, and a smaller AgNOR area to nucleus ratio. Longer disease-free survival time correlated with a smaller number of AgNORs per nucleus, a larger mean AgNOR area, a larger maximal AgNOR area, and a larger total AgNOR area. This study clearly demonstrates the additional benefit of the use of AgNORs in predicting treatment outcome in dogs with malignant lymphoma.


This article has been cited by other articles:


Home page
J DAIRY SCIHome page
L. F. P. Silva, B. E. Etchebarne, M. S. Weber Nielsen, J. S. Liesman, M. Kiupel, and M. J. VandeHaar
Intramammary Infusion of Leptin Decreases Proliferation of Mammary Epithelial Cells in Prepubertal Heifers
J Dairy Sci, August 1, 2008; 91(8): 3034 - 3044.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. A. Higgins, J. H. Rossmeisl, G. K. Saunders, S. Hayes, and M. Kiupel
B-Cell Lymphoma in the Peripheral Nerves of a Cat
Vet. Pathol., January 1, 2008; 45(1): 54 - 57.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Animal Hospital AssociationHome page
J. D. Frank, S. B. Reimer, P. H. Kass, and M. Kiupel
Clinical Outcomes of 30 Cases (1997 2004) of Canine Gastrointestinal Lymphoma
J. Am. Anim. Hosp. Assoc., November 1, 2007; 43(6): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. D. Webster, V. Yuzbasiyan-Gurkan, R. A. Miller, J. B. Kaneene, and M. Kiupel
Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication
Vet. Pathol., May 1, 2007; 44(3): 298 - 308.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Animal Hospital AssociationHome page
C. I. Kaiser, J. L. Fidel, M. Roos, and B. Kaser-Hotz
Reevaluation of the University of Wisconsin 2-Year Protocol for Treating Canine Lymphosarcoma
J. Am. Anim. Hosp. Assoc., March 1, 2007; 43(2): 85 - 92.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. Meyer, J. DeLay, and D. Bienzle
Clinical, laboratory, and histopathologic features of equine lymphoma.
Vet. Pathol., November 1, 2006; 43(6): 914 - 924.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. Pinard, C. R. Wagg, C. Girard, M. Kiupel, and C. Bedard
Histiocytic sarcoma in the tarsus of a cat.
Vet. Pathol., November 1, 2006; 43(6): 1014 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
V. E. Valli, W. Vernau, L.-P de Lorimier, P. S. Graham, and P. F. Moore
Canine Indolent Nodular Lymphoma
Vet. Pathol., May 1, 2006; 43(3): 241 - 256.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
P. Vajdovich, R. Psader, Z. A. Toth, and E. Perge
Use of the Argyrophilic Nucleolar Region Method for Cytologic and Histologic Examination of the Lymph Nodes in Dogs
Vet. Pathol., July 1, 2004; 41(4): 338 - 345.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
C. Fournel-Fleury, F. Ponce, P. Felman, A. Blavier, C. Bonnefont, L. Chabanne, T. Marchal, J. L. Cadore, I. Goy-Thollot, D. Ledieu, et al.
Canine T-cell Lymphomas: A Morphological, Immunological, and Clinical Study of 46 New Cases
Vet. Pathol., January 1, 2002; 39(1): 92 - 109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Veterinary Pathologists.